Quest Laboratories

Quest Laboratories EBITDA per Share

The EBITDA per Share of Quest Laboratories (QUESTLAB.NS) as of Oct 18, 2026 is 9.75 INR. In the previous year, EBITDA per Share was 13.04 INR — a change of -25.18% (lower).

EBITDA per Share

9.75INR

YoY

-25.18%

Last updated:

EBITDA per Share of Quest Laboratories is 2025 9.75 INR. EBITDA per Share of Quest Laboratories was 2024 13.04 INR. It decreases by -25.18% lower compared to the previous year.

The Quest Laboratories EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
4.77 INR
Jan 1, 2024
13.04 INR
Jan 1, 2025
9.75 INR
The Quest Laboratories EBITDA per Share history
YEAREBITDA per ShareYoY
9.75INR-25.18%
13.04INR+173.07%
4.77INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Laboratories Stock analysis

What does Quest Laboratories do? Quest Laboratories Ltd is an Indian pharmaceutical manufacturer headquartered in Dhar, Madhya Pradesh, which listed its shares on the stock exchange on 23 May 2024. The company produces a wide range of pharmaceutical formulations, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants. Its product portfolio encompasses ethical drugs, generic medicines, and over-the-counter items, available in diverse forms such as tablets, liquid orals, oral dry powders, oral rehydration salts, ointments, and external liquids. Specific offerings include Cetirizine Hydrochloride and Diclofenac Sodium tablets, as well as Ferrous Sulphate & Folic Acid syrup and Albendazole suspension. The firm also manufactures Silver Sulphadiazine cream and Diclofenac Diethylamino gel. By manufacturing these varied therapeutic agents, Quest Laboratories serves the domestic healthcare market with a focus on accessible and essential medicinal products. The company’s operations are centered on the production and distribution of these critical health care solutions within India. Quest Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quest Laboratories stock

EBITDA per Share of Quest Laboratories is 9.75 INR in 2025.

EBITDA per Share of Quest Laboratories changed from 13.04 INR to 9.75 INR, representing a -25.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Quest Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Quest Laboratories

All Key Metrics — Quest Laboratories